See more : Oblong, Inc. (OBLG) Income Statement Analysis – Financial Results
Complete financial analysis of Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jilin Zixin Pharmaceutical Industrial Co.,Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Tantia Constructions Limited (TANTIACONS.NS) Income Statement Analysis – Financial Results
- BlackBerry Limited (BB.TO) Income Statement Analysis – Financial Results
- Restaurant Brands International Limited Partnership (RSTRF) Income Statement Analysis – Financial Results
- Strides Pharma Science Limited (STAR.BO) Income Statement Analysis – Financial Results
- Lion One Metals Limited (LLO.AX) Income Statement Analysis – Financial Results
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (002118.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jilinzixin.com.cn
About Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. It provides ginseng drugs, prescription drugs, and OTC drugs. The company offers its products in the form of pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, and lozenges. Jilin Zixin Pharmaceutical Industrial Co.,Ltd was founded in 1998 and is based in Changchun, China.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 143.51M | 246.79M | 285.54M | 859.29M | 1.32B | 1.33B | 819.52M | 633.26M | 775.71M | 474.67M | 418.50M | 927.62M | 642.42M | 256.29M | 223.33M | 170.65M | 123.40M | 121.94M | 106.42M | 87.40M |
| Cost of Revenue | 50.11M | 109.97M | 122.55M | 201.92M | 465.87M | 269.58M | 213.90M | 210.18M | 347.91M | 146.83M | 152.41M | 424.92M | 289.94M | 59.85M | 53.31M | 41.91M | 28.62M | 29.27M | 21.53M | 16.68M |
| Gross Profit | 93.40M | 136.83M | 162.99M | 657.36M | 859.09M | 1.06B | 605.62M | 423.08M | 427.80M | 327.83M | 266.09M | 502.70M | 352.47M | 196.43M | 170.02M | 128.74M | 94.78M | 92.68M | 84.89M | 70.72M |
| Gross Profit Ratio | 65.08% | 55.44% | 57.08% | 76.50% | 64.84% | 79.69% | 73.90% | 66.81% | 55.15% | 69.07% | 63.58% | 54.19% | 54.87% | 76.65% | 76.13% | 75.44% | 76.81% | 76.00% | 79.77% | 80.92% |
| Research & Development | 6.72M | 10.11M | 16.07M | 40.36M | 45.57M | 41.03M | 14.94M | 14.49M | 22.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 26.08M | 50.55M | 44.81M | 47.17M | 58.29M | 78.00M | 67.83M | 53.13M | 42.35M | 103.76M | 78.45M | 78.91M | 42.78M | 25.70M | 17.13M | 13.67M | 11.31M | 13.45M | 10.23M | 8.96M |
| Selling & Marketing | 99.61M | 104.28M | 56.01M | 92.00M | 151.22M | 158.26M | 91.98M | 120.09M | 121.82M | 89.09M | 72.95M | 144.69M | 101.35M | 85.69M | 78.59M | 54.21M | 33.59M | 32.42M | 30.38M | 23.09M |
| SG&A | 125.69M | 154.83M | 100.82M | 139.17M | 209.51M | 236.25M | 159.81M | 173.22M | 164.18M | 192.84M | 151.40M | 223.60M | 144.13M | 111.38M | 95.72M | 67.87M | 44.90M | 45.87M | 40.61M | 32.05M |
| Other Expenses | 160.38M | 138.33M | 121.83M | 45.05M | -3.96M | -26.25M | 39.33M | 35.41M | 30.13M | 12.32M | 27.63M | 39.37M | -3.82M | 10.32M | 3.26M | 4.19M | 2.91M | 65.03K | 342.27K | 1.52M |
| Operating Expenses | 292.79M | 303.28M | 238.71M | 224.57M | 410.15M | 388.41M | 287.94M | 278.81M | 263.39M | 197.19M | 154.45M | 231.78M | 148.68M | 114.08M | 98.29M | 69.76M | 46.62M | 47.23M | 41.87M | 33.14M |
| Cost & Expenses | 342.90M | 413.24M | 361.26M | 426.49M | 876.01M | 657.99M | 501.84M | 489.00M | 611.30M | 344.02M | 306.87M | 656.70M | 438.62M | 173.94M | 151.60M | 111.67M | 75.24M | 76.50M | 63.40M | 49.82M |
| Interest Income | 25.66K | 18.90K | 35.22K | 87.98K | 261.88K | 1.91M | 1.38M | 355.56K | 363.24K | 833.96K | 2.46M | 7.37M | 303.86K | 383.99K | 521.07K | 573.10K | 38.53K | 32.93K | 3.24M | 8.44K |
| Interest Expense | 462.44M | 476.80M | 353.20M | 318.83M | 244.77M | 190.35M | 156.23M | 138.82M | 135.89M | 91.11M | 70.20M | 60.90M | 26.07M | 9.27M | 8.17M | 4.13M | 2.98M | 3.68M | 1.77M | 1.28M |
| Depreciation & Amortization | 68.69M | 100.94M | 125.46M | 111.38M | 104.24M | 102.66M | 75.38M | 67.72M | 59.49M | 41.00M | 32.61M | 29.19M | 24.02M | 21.59M | 18.09M | 6.63M | 5.21M | 5.92M | 5.15M | 3.51M |
| EBITDA | -130.71M | -65.51M | 83.07M | 546.75M | 558.30M | 749.61M | 443.02M | 256.32M | 262.08M | 194.58M | 176.28M | 352.47M | 226.14M | 105.44M | 85.74M | 66.55M | 53.06M | 51.69M | 51.55M | 40.85M |
| EBITDA Ratio | -91.08% | -26.54% | 29.09% | 63.63% | 42.14% | 56.48% | 54.06% | 40.48% | 33.79% | 40.99% | 42.12% | 38.00% | 35.20% | 41.14% | 38.39% | 39.00% | 43.00% | 42.39% | 48.44% | 46.74% |
| Operating Income | -199.40M | -166.45M | -42.39M | 435.37M | 216.10M | 464.56M | 160.60M | 8.61M | 16.28M | 41.84M | 65.54M | 193.47M | 178.57M | 68.96M | 63.49M | 54.46M | 45.06M | 42.12M | 44.28M | 36.06M |
| Operating Income Ratio | -138.95% | -67.45% | -14.84% | 50.67% | 16.31% | 35.00% | 19.60% | 1.36% | 2.10% | 8.81% | 15.66% | 20.86% | 27.80% | 26.91% | 28.43% | 31.91% | 36.52% | 34.54% | 41.61% | 41.26% |
| Total Other Income/Expenses | -950.47M | -817.03M | -709.95M | -348.76M | -3.96M | -26.25M | 39.33M | 35.41M | 29.80M | 12.28M | 27.20M | 39.32M | -3.89M | 1.03M | -4.49M | -969.41K | -185.18K | -34.97K | 342.27K | -2.08K |
| Income Before Tax | -1.15B | -983.48M | -752.34M | 86.61M | 212.14M | 438.32M | 199.92M | 44.01M | 46.08M | 54.12M | 92.74M | 232.78M | 174.68M | 69.99M | 58.99M | 53.49M | 44.88M | 42.08M | 44.62M | 36.06M |
| Income Before Tax Ratio | -801.27% | -398.51% | -263.48% | 10.08% | 16.01% | 33.02% | 24.40% | 6.95% | 5.94% | 11.40% | 22.16% | 25.09% | 27.19% | 27.31% | 26.42% | 31.35% | 36.37% | 34.51% | 41.93% | 41.26% |
| Income Tax Expense | 39.39M | 14.63M | -46.58M | 16.38M | 38.15M | 66.90M | 37.25M | 4.78M | -870.05K | 3.65M | 6.43M | 15.50M | 1.52M | 8.91M | 5.66M | 5.53M | 15.43M | 13.65M | 14.83M | 11.90M |
| Net Income | -1.19B | -998.11M | -705.76M | 70.29M | 174.07M | 371.58M | 163.17M | 39.59M | 47.19M | 50.48M | 86.31M | 217.29M | 173.17M | 61.08M | 53.34M | 47.95M | 29.45M | 28.22M | 29.36M | 24.16M |
| Net Income Ratio | -828.72% | -404.44% | -247.17% | 8.18% | 13.14% | 28.00% | 19.91% | 6.25% | 6.08% | 10.63% | 20.62% | 23.42% | 26.96% | 23.83% | 23.88% | 28.10% | 23.86% | 23.14% | 27.59% | 27.64% |
| EPS | -0.93 | -0.78 | -0.55 | 0.05 | 0.14 | 0.29 | 0.13 | 0.04 | 0.05 | 0.05 | 0.09 | 0.21 | 0.19 | 0.08 | 0.06 | 0.11 | 0.05 | 0.05 | 0.05 | 0.04 |
| EPS Diluted | -0.93 | -0.78 | -0.55 | 0.05 | 0.14 | 0.29 | 0.13 | 0.04 | 0.05 | 0.05 | 0.09 | 0.21 | 0.19 | 0.08 | 0.06 | 0.11 | 0.05 | 0.05 | 0.05 | 0.04 |
| Weighted Avg Shares Out | 1.28B | 1.28B | 1.28B | 1.41B | 1.24B | 1.28B | 1.26B | 989.79M | 1.05B | 1.01B | 1.02B | 1.03B | 936.07M | 814.38M | 824.34M | 440.61M | 621.92M | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.28B | 1.28B | 1.28B | 1.41B | 1.24B | 1.28B | 1.26B | 989.79M | 1.05B | 1.01B | 1.02B | 1.03B | 936.07M | 814.38M | 824.34M | 440.61M | 621.92M | 0.00 | 0.00 | 0.00 |
No news found for: 002118.SZ
Source: https://incomestatements.info
Category: Stock Reports